| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BBRC.2008.07.060 |
| P698 | PubMed publication ID | 18655770 |
| P2093 | author name string | Bin Zhang | |
| Guo Wei | |||
| Meng Zhang | |||
| Huafeng Wei | |||
| Xiaokang Liu | |||
| Guanghua Rong | |||
| Liye Ma | |||
| Guoen Fang | |||
| Jianwei Bi | |||
| Xuchao Xue | |||
| P2860 | cites work | Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells | Q27860460 |
| Transforming growth factor-beta induces development of the T(H)17 lineage | Q28237370 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 533-537 | |
| P577 | publication date | 2008-07-23 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | The prevalence of Th17 cells in patients with gastric cancer | |
| P478 | volume | 374 |
| Q35886607 | A multi-epitope vaccine CTB-UE relieves Helicobacter pylori-induced gastric inflammatory reaction via up-regulating microRNA-155 to inhibit Th17 response in C57/BL6 mice model |
| Q35905076 | Aberrant Circulating Th17 Cells in Patients with B-Cell Non-Hodgkin's Lymphoma |
| Q54620397 | Analysis of the association of interleukin-17 gene polymorphisms with gastric cancer risk and interaction with Helicobacter pylori infection in a Chinese population. |
| Q34213872 | Association analysis of IL-17A and IL-17F polymorphisms in Chinese Han women with breast cancer |
| Q36294244 | Association between IL17 polymorphisms and risk of cervical cancer in Chinese women |
| Q37696135 | Associations of genotypes and haplotypes of IL-17 with risk of gastric cancer in an eastern Chinese population |
| Q37695090 | Cellular mediators of inflammation: tregs and TH17 cells in gastrointestinal diseases. |
| Q64893996 | Clinical efficacy of apatinib in treating metastatic gastric cancer and its effect on IL-17. |
| Q52951871 | Clinical relevance of the number of interleukin-17-producing CD 8+ T cells in patients with gastric cancer. |
| Q36947101 | Clinical significance of T-bet, GATA-3, and Bcl-6 transcription factor expression in bladder carcinoma. |
| Q35032514 | Decreased expression of the FOXO3a gene is associated with poor prognosis in primary gastric adenocarcinoma patients |
| Q82254278 | Differences in T-helper polarizing capability between human monocyte-derived dendritic cells and monocyte-derived Langerhans'-like cells |
| Q41553599 | Effects of the Treg/Th17 cell balance and their associated cytokines in patients with hepatitis B infection |
| Q37645126 | Elevated Th22 cells correlated with Th17 cells in peripheral blood of patients with acute myeloid leukemia |
| Q84491113 | Expression of interleukin-17 and its clinical significance in gastric cancer patients |
| Q34575695 | Extracellular ATP and Toll-like receptor 2 agonists trigger in human monocytes an activation program that favors T helper 17 |
| Q64071947 | Gastric Cancer Stem Cells Effect on Th17/Treg Balance; A Bench to Beside Perspective |
| Q35195785 | Gut microbiota, immunity, and disease: a complex relationship |
| Q92259788 | Helicobacter pylori Deregulates T and B Cell Signaling to Trigger Immune Evasion |
| Q61521806 | Helicobacter pylori secreted peptidyl prolyl cis, trans-isomerase drives Th17 inflammation in gastric adenocarcinoma |
| Q34276831 | Human CCR4+ CCR6+ Th17 cells suppress autologous CD8+ T cell responses |
| Q39650631 | Human Th17 cells can be induced through head and neck cancer and have a functional impact on HNSCC development |
| Q37144134 | Human papillomavirus infection correlates with inflammatory Stat3 signaling activity and IL-17 expression in patients with breast cancer |
| Q36302527 | IEX-1 deficiency protects against colonic cancer |
| Q37937750 | IFN-γ, IL-17 and TGF-β involvement in shaping the tumor microenvironment: The significance of modulating such cytokines in treating malignant solid tumors. |
| Q34989745 | IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway |
| Q34690808 | IL-17 enhances tumor development in carcinogen-induced skin cancer |
| Q35847817 | IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma |
| Q38819668 | IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer |
| Q90220080 | IL-17-Producing Cells in Tumor Immunity: Friends or Foes? |
| Q33907311 | IL-23/IL-27 Ratio in Peripheral Blood of Patients with Breast Cancer |
| Q53268660 | IL-23R polymorphisms, HBV infection, and risk of hepatocellular carcinoma in a high-risk Chinese population. |
| Q92582058 | IL‑17A promotes CXCR2‑dependent angiogenesis in a mouse model of liver cancer |
| Q92619203 | Imbalance of Th1/Th2 and Th17/Treg during the development of uterine cervical cancer |
| Q35203067 | Immune derangements in patients with myelofibrosis: the role of Treg, Th17, and sIL2Rα. |
| Q34569251 | Impact of stress on cancer metastasis |
| Q43276074 | Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. |
| Q36864299 | Increased Th17 cells in the tumor microenvironment is mediated by IL-23 via tumor-secreted prostaglandin E2. |
| Q47421892 | Increased circulating Th22 and Th17 cells are associated with tumor progression and patient survival in human gastric cancer |
| Q39020805 | Increased expression of IL17A in human gastric cancer and its potential roles in gastric carcinogenesis |
| Q84527284 | Increased frequencies of T helper type 17 cells in the peripheral blood of patients with acute myeloid leukaemia |
| Q44779348 | Increased prevalence of T(H)17 cells in the peripheral blood of patients with head and neck squamous cell carcinoma |
| Q36957222 | Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer |
| Q34570874 | Inhibition of IL-17A in tumor microenvironment augments cytotoxicity of tumor-infiltrating lymphocytes in tumor-bearing mice |
| Q38674886 | Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in Cancer |
| Q52728029 | Interleukin 17 and peripheral IL-17-expressing T cells are negatively correlated with the overall survival of head and neck cancer patients. |
| Q33961542 | Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression. |
| Q37153011 | Interleukin-17 Expression in the Barrett's Metaplasia-Dysplasia-Adenocarcinoma Sequence |
| Q92740824 | Interleukin-17 is associated with expression of programmed cell death 1 ligand 1 in ovarian carcinoma |
| Q36242082 | Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells via the STAT3/GIV signaling pathway in non-small-cell lung cancer |
| Q35666465 | Interleukin-17-induced EMT promotes lung cancer cell migration and invasion via NF-κB/ZEB1 signal pathway |
| Q53212282 | Interleukin-17A Plays a Pivotal Role in Chemically Induced Hepatocellular Carcinoma in Mice. |
| Q55344084 | Interleukin-17A Promotes Parietal Cell Atrophy by Inducing Apoptosis. |
| Q41897122 | Interleukin-17D mediates tumor rejection through recruitment of natural killer cells |
| Q34487114 | Intratumoral expression of IL-17 and its prognostic role in gastric adenocarcinoma patients |
| Q33712435 | Lymphocytes in cancer development: polarization towards pro-tumor immunity |
| Q41592822 | MM-BMSCs induce naïve CD4+ T lymphocytes dysfunction through fibroblast activation protein α |
| Q42709546 | Molecular cross-talk between Helicobacter pylori and human gastric mucosa |
| Q56986695 | Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival |
| Q98280908 | Myeloid-derived suppressor cell depletion therapy targets IL-17A-expressing mammary carcinomas |
| Q64075903 | NCR group 3 innate lymphoid cells orchestrate IL-23/IL-17 axis to promote hepatocellular carcinoma development |
| Q39434888 | Pathogenic Role of IL-17-Producing Immune Cells in Obesity, and Related Inflammatory Diseases |
| Q34325926 | Persistent Helicobacter pylori specific Th17 responses in patients with past H. pylori infection are associated with elevated gastric mucosal IL-1β |
| Q37162474 | Polymorphism in the interleukin-17A promoter contributes to gastric cancer. |
| Q36905859 | Preferential expression of functional IL-17R in glioma stem cells: potential role in self-renewal |
| Q34201267 | Promotion of lung tumor growth by interleukin-17 |
| Q33838828 | Reduced interleukin-17 and transforming growth factor Beta levels in peripheral blood as indicators for following the course of bladder cancer |
| Q33711756 | Regulation of Gastric Carcinogenesis by Inflammatory Cytokines. |
| Q42004790 | Regulation of T helper 17 by bacteria: an approach for the treatment of hepatocellular carcinoma |
| Q92259805 | Resolution of Gastric Cancer-Promoting Inflammation: A Novel Strategy for Anti-cancer Therapy |
| Q34976906 | Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism |
| Q34737528 | Retracted: IL-26 Promotes the Proliferation and Survival of Human Gastric Cancer Cells by Regulating the Balance of STAT1 and STAT3 Activation |
| Q38270824 | Role of IL-17 in Glioma Progression |
| Q40979257 | Role of T helper 17 cytokines in the tumour immune inflammation response of patients with laryngeal squamous cell carcinoma |
| Q87610387 | Significant association between interleukin-17A polymorphism and colorectal cancer |
| Q52729761 | Stromal C-type lectin receptor COLEC12 integrates H. pylori, PGE2-EP2/4 axis and innate immunity in gastric diseases. |
| Q34568217 | Stromal cells induce Th17 during Helicobacter pylori infection and in the gastric tumor microenvironment |
| Q91724018 | Systemic Th17 response in the presence of periodontal inflammation |
| Q38018319 | T cells in gastric cancer: friends or foes |
| Q24646584 | T helper 17 cells promote cytotoxic T cell activation in tumor immunity |
| Q35623903 | T(H)17 cells in tumour immunity and immunotherapy. |
| Q34276027 | TGFβ in T cell biology and tumor immunity: Angel or devil? |
| Q28066522 | Targeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer Type |
| Q35093526 | Tc17 cells in patients with uterine cervical cancer |
| Q40516989 | Th1-, Th2-, and Th17-associated cytokine expression in hypopharyngeal carcinoma and clinical significance |
| Q37239790 | Th17 and Treg cells in bone related diseases |
| Q47218277 | Th17, synchronically increased with Treg and Breg, promoted by tumor cells via cell-contact in primary hepatic carcinoma. |
| Q36808542 | The Th17/Treg balance and the expression of related cytokines in Uygur cervical cancer patients |
| Q33869683 | The accumulation and prognosis value of tumor infiltrating IL-17 producing cells in esophageal squamous cell carcinoma |
| Q31096343 | The changes of Th17 cells and the related cytokines in the progression of human colorectal cancers |
| Q33715287 | The distribution and function of human memory T cell subsets in lung cancer |
| Q54390200 | The expression of interleukin (IL)-17 and IL-17 receptor and MMP-9 in human pituitary adenomas. |
| Q38121412 | The immune network in pancreatic cancer development and progression. |
| Q26745703 | The interplay between the microbiome and the adaptive immune response in cancer development |
| Q35839920 | The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection |
| Q38211077 | The role of inflammation in prostate cancer |
| Q37781690 | Up for Mischief? IL-17/Th17 in the tumour microenvironment |
| Q34075574 | Up-regulation of Th17 cells may underlie inhibition of Treg development caused by immunization with activated syngeneic T cells |
| Q55429746 | [Research advances on Th17 cells in tumor]. |
| Q36294199 | miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer |
| Q24299080 | microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer |
| Q33609703 | β-Catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells |
Search more.